To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

rhBMP-7 results in higher union rates compared to PRP in treatment of long bone non-unions

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2013

rhBMP-7 results in higher union rates compared to PRP in treatment of long bone non-unions

Vol: 2| Issue: 3| Number:182| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions - A prospective randomised clinical study on 120 patients

Injury. 2008 Dec;39(12):1391-402. Epub 2008 Nov 22

Contributing Authors:
GM Calori L Tagliabue L Gala M d\'Imporzano G Peretti W Albisetti

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

120 patients with persistent long bone fracture non-unions were randomized to either receive recombinant bone morphogenic protein (rhBMP-7) or platelet-rich plasma (PRP). The results at a mean follow-up of 12 months indicated that rhBMP-7 had superior clinical and radiographic effectiveness compared to platelet-rich plasma. RhBMP-7 resulted in a greater percentage of non-unions that achieved clini...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue